Home » Topics » BioWorld Science

BioWorld Science
RSS

Intranasal octreotide formulation DP-1038 demonstrates viability in healthy volunteers

March 21, 2018

Antibe Therapeutics' ATB-346 shows better gastrointestinal safety in phase IIb study

March 21, 2018

Ocugen's phase II study of OCU-310 demonstrates proof-of-concept for dry eye disease

March 21, 2018

FDA clears Therapix's IND for phase IIa study of THX-110

March 21, 2018

FDA expands approval of Adcetris

March 21, 2018

Novel orthoIL-2/IL-2R pairs show efficacy in mouse model of melanoma

March 21, 2018

Immunicum obtains ATMP certificate from EMA for ilixadencel

March 21, 2018

MJFF announces funding for investigator-initiated projects in Parkinson's disease

March 21, 2018

Institut Pasteur de Montevideo and Universidad de la Republica describe new trolox derivatives

March 21, 2018

Suven Life Sciences patents new muscarinic M1 receptor PAMs

March 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...